Ebb & Flow Focus
After raising the ante, Biogen Idec Inc. is now officially available for sale. Last Friday, the company said it would evaluate whether shareholder value would be best served via an acquisition or remaining as a standalone company.
BIIB (Cambridge, Mass.) also disclosed it had "received expressions of interest, including one from investor Carl Icahn."
The Street has pushed BIIB up steadily from a bottom of about $45 in March, aided by a share buyback via Dutch auction in early